News

Published on 8 Sep 2022 on Investing.com

Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday By Benzinga


Article preview image

Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday

NASDAQ.LTCH price evolution
NASDAQ.MCRB price evolution
NASDAQ.AVCT price evolution
NYSE.GKOS price evolution
NASDAQ.SPWR price evolution
NYSE.TPX price evolution
NASDAQ.AQST price evolution
NASDAQ.RETA price evolution
NASDAQ.NBEV price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Here's Why You Should Retain Glaukos (GKOS) in Your Portfolio

Glaukos Corporation GKOS is well-poised for growth, backed by favorable clinical trial results an...

Zacks via Yahoo Finance 23 Nov 2022

Glaukos (GKOS) Beats on Q3 Earnings, Tightens Sales View

Glaukos Corporation GKOS reported an adjusted loss per share of 45 cents for the third quarter of...

Zacks via Yahoo Finance 3 Nov 2022

Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates

Glaukos (GKOS) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estim...

Zacks via Yahoo Finance 2 Nov 2022

The Zacks Analyst Blog Highlights Nevro, Masimo, Abiomed and Glaukos

For Immediate Release Chicago, IL – October 28, 2022 – Zacks.com announces the list of stocks fea...

Zacks via Yahoo Finance 28 Oct 2022

Glaukos (GKOS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street expects a year-over-year decline in earnings on lower revenues when Glaukos (GKOS) re...

Zacks via Yahoo Finance 26 Oct 2022

Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday By Benzinga

Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday

Investing.com 8 Sep 2022

Glaukos (GKOS) Up on Positive Glaucoma Study Data on iDose TR

Glaukos Corporation GKOS announced positive top-line data from two pivotal studies evaluating its...

Zacks via Yahoo Finance 8 Sep 2022

GKOS stock gains as pivotal trials for eye implant reach main goals (NYSE:GKOS)

Glaukos Corporation (GKOS), a MedTech company focused on eye diseases, announced Wednesday that t...

Seeking Alpha 7 Sep 2022

Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate

Glaukos Corporation (NASDAQ: GKOS) announced positive topline data for both Phase 3 trials of iDo...

Benzinga via Yahoo Finance 7 Sep 2022

Glaukos (GKOS) Strong Portfolio Driving Sales Amid Competition

Glaukos Corporation GKOS is focused on the development and commercialization of novel surgical de...

Zacks via Yahoo Finance 15 Aug 2022